These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 19482212)
21. Ischaemia versus bleeding: the art of clinical decision-making. Stone GW Lancet; 2009 Feb; 373(9665):695-6. PubMed ID: 19249613 [No Abstract] [Full Text] [Related]
22. Outcomes in patients with ST-segment elevation acute myocardial infarction treated with clopidogrel versus prasugrel (from the INFUSE-AMI trial). Brener SJ; Oldroyd KG; Maehara A; El-Omar M; Witzenbichler B; Xu K; Mehran R; Gibson CM; Stone GW Am J Cardiol; 2014 May; 113(9):1457-60. PubMed ID: 24630789 [TBL] [Abstract][Full Text] [Related]
23. Platelet inhibitors: update on clopidogrel (Plavix) and the recently approved prasugrel (Effient). Wynn RL Gen Dent; 2010; 58(1):7-9. PubMed ID: 20129886 [No Abstract] [Full Text] [Related]
24. Is prasugrel more effective than clopidogrel at preventing future cardiac events? Lange CG JAAPA; 2011 Feb; 24(2):52, 55. PubMed ID: 21387971 [No Abstract] [Full Text] [Related]
25. [Prasugrel versus Clopidogrel in patients with acute coronary syndromes. Results of the TRITON-TIMI 38 trial]. Preobrazhenskiĭ DV Kardiologiia; 2008; 48(8):72-3. PubMed ID: 18789014 [No Abstract] [Full Text] [Related]
26. Drug interactions with good old clopidogrel: case closed. Verheugt FW JACC Cardiovasc Interv; 2013 Dec; 6(12):1282-3. PubMed ID: 24239200 [No Abstract] [Full Text] [Related]
28. Early and late benefits of prasugrel in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a TRITON-TIMI 38 (TRial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet InhibitioN with Prasugrel-Thrombolysis In Myocardial Infarction) analysis. Antman EM; Wiviott SD; Murphy SA; Voitk J; Hasin Y; Widimsky P; Chandna H; Macias W; McCabe CH; Braunwald E J Am Coll Cardiol; 2008 May; 51(21):2028-33. PubMed ID: 18498956 [TBL] [Abstract][Full Text] [Related]
29. [Prasugrel versus clopidogrel. From the American Heart Association meeting, 2007]. Schaerlig E Rev Med Suisse; 2008 Feb; 4(144):434-5. PubMed ID: 18320775 [No Abstract] [Full Text] [Related]
30. Intensive antiplatelet therapy for reduction of ischaemic events. Ramaraj R Lancet; 2008 Aug; 372(9638):531; author reply 532. PubMed ID: 18707975 [No Abstract] [Full Text] [Related]
31. Excess rates of nonfatal myocardial infarction in the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel (preventing clinical events or chasing enzymatic ghosts?). Serebruany VL Am J Cardiol; 2008 May; 101(9):1364-6. PubMed ID: 18435973 [No Abstract] [Full Text] [Related]